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Abstract 
Purpose 
Colorectal cancer is highly preventable by detecting and removing polyps, which are the precursors. 
Currently, the most accurate test is colonoscopy, but still misses 22% of polyps due to visualization 20 
limitations. In this paper we preliminary assess the potential of microwave imaging and dielectric properties 
(e.g. complex permittivity) as a complementary method for detecting polyps and cancer tissue in the colon. 
The dielectric properties of biological tissues have been used in a wide variety of applications, including 
safety assessment of wireless technologies and design of medical diagnostic or therapeutic techniques 
(microwave imaging, hyperthermia and ablation). The main purpose of this work is to measure the complex 25 
permittivity of different types of colon polyps, cancer and normal mucosa in ex vivo human samples to study 
if the dielectric properties are appropriate for classification purposes.  
Methods 
The complex permittivity of freshly excised healthy colon tissue, cancer and histological samples of different 
types of polyps from 23 patients was characterized using an open-ended coaxial probe between 0.5 and 20 30 
GHz. The obtained measurements were classified into five tissue groups before applying a data reduction 
step with a frequency dispersive single-pole Debye model. The classification was finally compared with 
pathological analysis of tissue samples, which is the gold standard. 
Results 
The complex permittivity progressively increases as the tissue degenerates from normal to cancer. When 35 
comparing to the gold-standard histological tissue analysis, the sensitivity and specificity of the proposed 
method is the following: 100% and 95% for cancer diagnosis; 91% and 62% for adenomas with high grade 
dysplasia; 100% and 61% for adenomas with low grade dysplasia; and 100% and 74% for hyperplastic polyps, 
respectively. In addition, complex permittivity measurements were independent of the lesion shape and size, 
which is also an interesting property comparing to current colonoscopy techniques. 40 
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Conclusions 
The contrast in complex permittivities between normal and abnormal colon tissues presented here for the 
first time demonstrate the potential of these measurements for tissue classification. It also opens the door 
to the development of a microwave endoscopic device to complement the outcomes of colonoscopy with 
functional tissue information. 45 
Key words: colorectal cancer, dielectric characterization, ex vivo tissues, microwave imaging, Debye model 
1. Introduction 
Colorectal cancer (CRC) is a serious and increasing health problem in countries with a Westernized lifestyle 
where, in average, affects 1 in 20 men and 1 in 30 women over 50 years old1.  Worldwide CRC is the third most 
common cancer and the fourth most deadly one just behind lung, liver and stomach cancer2. In average, the 5-50 
year survival rate is 65%, however it is highly dependent on the stage of diagnosis.  Fortunately, CRC is a disease 
that can be cured in more than 90% of patients if detected at an early stage3. The development of CRC is 
characterized by an ordered series of events that are referred to as adenoma-carcinoma sequence: healthy 
mucosa develops dysplasia and forms small polyps, called adenomas, which may grow and eventually become 
adenocarcinomas4 unless resected5. Several systematic reviews of the literature have shown that CRC screening 55 
is cost-effective and prospective studies with a large number of cases demonstrate a reduction in CRC risk during 
follow-up patients undergoing colonoscopy screening6, which is the standard in clinical routine. Besides 
colonoscopy, there are other methods for CRC screening such as stool-based tests, double-contrast barium 
edema and CT colonography7. If there is suspicion of polyps in these tests, a colonoscopy will be needed 7.   
To date, colonoscopy is the most effective diagnostic and therapeutic technique for the prevention of CRC, since 60 
it allows the identification of polyps with a relatively good accuracy. It is also the only method able to remove 
tissue samples (e.g. polyps) in the entire colon for subsequent histological analysis. Several prospective studies 
demonstrate that colonoscopy with polypectomy (removal of polyps) reduces the incidence of CRC by 40-90%8, 
9. Nevertheless colonoscopy is far from being perfect: 22% of polyps are not detected10 and the risk of cancer 
after a negative colonoscopy is still 7.9%11. The main cause of this lack of efficacy is the visualization limitation12 65 
of the optical camera placed at the tip of the endoscope. Studies indicate that 13.4% of the colon surface area 
might not be visualized during a standard colonoscopy13 due to reduced field of vision (< 180º), inhomogeneous 
illumination, colon angulations and folds, and poor cleaning. Another limitation of colonoscopy is the subjectivity 
in the assessment of several characteristics of the lesions such as size, position and tissue classification, which 
highly depends on the experience of the endoscopist. The final diagnosis is subsequently based on the results of 70 
the histological analysis of the resected tissues, which is considered the gold standard. As a security measure, 
current clinical guidelines3 therefore recommend removing all lesions found in a colonoscopy study, including 
small lesions (< 5 mm) that are often benign polyps. A pathologist then analyses all lesions and emits a histology 
report. This clinical workflow is labor- and time-intensive, making the processing of these patient data inefficient 
and significantly increasing the burden for the healthcare system. 75 
In recent years, several devices and technologies have been developed to improve the detection rate of polyps 
such as high definition endoscopes, endoscopes with multiple lenses (retrovision capability), and mucosal 
flattening accessories14. Advances in computer vision may also help in the detection of morphological changes 
in colon images, such as shape, color or texture15, which may indicate the presence of an abnormality. The 
current trend in colonoscopy is to provide additional information during the exploration (often called in situ 80 
diagnosis) to help doctors in their decision-making. For example, magnification14 of the image may help to detect 
morphological changes; electronic chromoendoscopy narrow band imaging may also enhance the visualization 
of the vascularization abnormalities related to cancer16. However, all these techniques exploit the same contrast 
mechanism based on the optical image, thus being restricted to information visualized with the camera at the 
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tip of the endoscope. To overcome this limitation a different contrast mechanism is needed. Some methods such 85 
as near infrared Raman17 or terahertz spectroscopy18 have also been proposed for cancer diagnosis purposes. 
However, there is not a technique yet that can distinguish between benign and malignant lesions during the 
study.  
Microwave imaging has the potential to complement conventional colonoscopy to improve both polyp detection 
rate and in situ tissue classification. Microwaves can generate images without restriction of the field of view 90 
(360°) and offer a fair trade-off between resolution and light opaque tissue penetration19, therefore potentially 
reducing visualization problems of conventional colonoscopy. In addition, microwaves can provide a quantitative 
differentiation of normal and abnormal tissues based in their dielectric properties20. Finally, the technology is 
safe (low power and non-ionizing radiation) and portable. For these reasons microwave imaging is a promising 
method for population screening, diagnosis and monitoring of cancer patients.  95 
Microwave imaging tries to evaluate objects hidden or embedded in a structure (or medium) using 
electromagnetic (EM) waves in the regime of the microwaves. In the field of medicine, microwaves have been 
established as a good solution for treatment of cancer (hyperthermia and ablation)21 and for monitoring of vital 
signs22. Furthermore, there is ongoing research studying microwave imaging for image-based diagnosis in an 
extensive number of applications: acute ischemia or cerebral hemorrhage23, pulmonary edema, urinary 100 
incontinence, osteoporosis24 and breast cancer detection25, 26; some of these studies are already in clinical 
phases27. As far as we know, microwave imaging has never been proposed before for endoscopic applications.  
To assess the feasibility of microwave imaging for CRC diagnosis it is crucial to have good dielectric contrast 
between healthy colon, different types of polyps and cancer tissues over the frequency band of interest. It has 
previously been demonstrated that the complex permittivity of some cancer and healthy tissues change 105 
noticeably20. However, to the best of our knowledge, there is not available data for normal and abnormal colon 
tissues in humans over 900 MHz. Done-Sik et al.28, 29 measured the complex permittivity of colon cancer and 
healthy colon of nude mice over 0.2-5 GHz band, while Joines et al.30 reported the complex permittivity of 
healthy and malignant colon human samples between 50-900 MHz band. Gabriel et al. extended the healthy 
colon measurements to the 0.5-20 GHz band using ovine models31-33.  110 
In this paper we present data from dielectric properties measured on ex vivo human samples of different types 
of colon polyps and healthy colon tissues, which was not available in the literature. Measurements on dielectric 
properties were acquired using the open-ended coaxial probe method across the frequency range 0.5 to 20 GHz. 
With this data we formed five groups of tissues based on the similarities in their dielectric properties. 
Subsequently, we reduced the data using a Debye model. The remainder of this paper is organized as follows. 115 
Section 2 describes the methodology for obtaining tissue samples, conducting dielectric spectroscopy and data 
analysis. Section 3 presents the results obtained from the human tissue study. Section 4 discusses the 
applicability of dielectric property data to colonoscopy tests. Finally, Section 5 summarizes the main conclusions 
of this study. 
2. Materials and Methods 120 
This work was performed at the Endoscopy Unit of Hospital Clínic of Barcelona (HCB), after being approved by 
the Ethical Committee of Clinical Investigation at HCB. All patients signed an informed consent permitting 
colorectal examinations and use of their data for research purposes. A total of 23 patients undergoing screening 
colonoscopies, polypectomies and surgical colectomies were enrolled in the study. Between 1 and 7 specimens 
per patient were collected, leading to a total of 59 freshly excised samples of different histological types of 125 
polyps, healthy colon and CRC tissue (Table I), thus providing a complete overview of the colon pathology. The 
measurement protocol was nondestructive for subsequent pathological analysis of the same sample and was 
designed to reduce the manipulation of the sample and the time between excision and measurement. 
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In the remaining of this section, we first present colon cancer disease and the existing tissue classification 
methods used in daily clinical routine. We then describe the protocol followed to measure the complex 130 
permittivity of freshly excised colon samples using a precision open-ended coaxial probe. A statistical analysis 
was carried out to assess the quality of the obtained measurements and the corresponding tissue classification 
based on dielectric data. We finally explain the fitting of the measured data to a single-pole Debye model. 
2.A. Classification of samples 
Colon polyps are slow-growing overgrowths of the colonic mucosa originating from superficial glandular 135 
epithelial cells lining in the colon and rectum, and generally protruding into the lumen. When a polyp 
degenerates into cancer it may infiltrate into the wall (invasive). Colon polyps can be classified according to their 
histological and shape characteristics, as following. Histology defines tissue and cell anatomy based on its 
appearance under the microscope and sets the grade of dysplasia (i.e. abnormality of development or cell 
anomaly of growth and differentiation). Depending on the grade of dysplasia, polyps can be diagnosed as either 140 
neoplastic or non-neoplastic, if they have lost its normal differentiation or not, respectively. Hyperplastic polyps 
are the most common type of non-neoplastic or benign proliferations of cells. Neoplastic lesions or adenomas 
can be categorized according to their histological appearance into: tubular, villous or tubulovillous34, and 
according to their grade of dysplasia. Adenomas with low-grade dysplasia (LGD) are more similar to healthy 
mucosa, while malignant adenomas can present high-grade dysplasia (HGD) or have already degenerated to 145 
adenocarcinoma35. Recently, serrated variants of polyps have been considered as a new category of neoplastic 
polyps because of their malignant potential36,37. Fig. 1 and Fig. 2 present pictures of five different colon tissue 
samples and their corresponding histology images, respectively. Histology images show the tissue composition 
and shape characteristics of the cells under study. Normal mucosa (see Fig. 2 (a)) is the innermost layer of colon 
wall, which is composed by epithelial cells that form glandular crypts, and connective tissue (called lamina 150 
propria) filling the empty spaces. Polyps are also composed by epithelial cells but with certain modifications: e.g. 
hyperplastic polyps (Fig. 2 (b)) present a serrated and dilated contour of the glandular crypts; tubular adenomas 
(Fig. 2 (c)) show elongated glandular crypts and cellular proliferation. Fig. 2 (d) shows the adenoma-carcinoma 
sequence in the same sample. An infiltrating adenocarcinoma is originated on a tubular adenoma that presents 
an in-situ adenocarcinoma in the middle. Finally, Fig. 2 (e) shows an invasive adenocarcinoma infiltrating the 155 
muscular layer. 
The shape of polyps is usually categorized during a colonoscopy exploration using the standard Paris 
classification38, as can be seen in Fig. 3. This classification method divides the polyps into protruded (e.g. 
pedunculated, Ip; sessile, Is), and non-protruded (e.g. slightly elevated, IIa; flat, IIb; slightly depressed, IIc; 
excavated, III). We measured 9 pedunculated, 11 sessile and 18 slightly elevated polyps. In general, small size 160 
and non-protruded polyps are the ones that report higher polyp miss rates39.  
For this study, we used freshly excised colon samples from 23 patients, from which we analyzed 38 polyps with 
different characteristics, as summarized in Table I; 11 samples of cancer and 10 samples of normal colon mucosa. 
 
FIG. 1. Pictures of five tissue specimens including: (a) healthy mucosa; (b) hyperplastic polyp of 8 mm; (c) tubular adenoma 165 
with low grade dysplasia of 12 mm; (d) tubular adenoma with high grade dysplasia of 25 mm; and (e) colon mucosa with an 
adenocarcinoma of 15 mm marked with a circle. 
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FIG. 2. (a) Normal mucosa composed of surface epithelium, glandular crypts and lamina propria. (b) Hyperplastic polyp 
showing a serrated and dilated contour of the glandular crypts. (c) Tubular adenoma with low grade dysplasia is similar to 170 
normal mucosa but presents increased proliferation of nuclei in the elongated crypts. (d) Adenoma-carcinoma sequence 
shown in the same lesion: residual tubular adenoma (left-short arrow) evolving into an in-situ adenocarcinoma in the middle 
(center-long arrow), and to an infiltrating adenocarcinoma (right arrowheads). (e) Infiltrating adenocarcinoma with epithelial 
glands (arrowheads) invading the muscular layer of the colon wall. 
 175 
 
FIG. 3. Morphological categories of polyps based on the standard Paris classification. The dotted line represents twice the 
thickness of the mucosa layer38. 
TABLE I. Morphology, size, and number of polyps by malignant potential (LGD, HGD, are low and high grade dysplasia, 
respectively) and total. 180 
Morphology Size (mm) LGD HGD N 
Tubular adenoma 6-25 16 6 22 
Villous adenoma 7 0 1 1 
Tubulovillous adenoma 25-60 2 0 2 
Hyperplastic  3-12 - - 8 
Sessile serrated 18 - - 5 
 
2.B. Measurement setup and calibration experiments 
The complex permittivity of polyps and cancer was measured using a Keysight 85070E dielectric probe kit with 
an open-ended high temperature coaxial probe40 connected to an Agilent E8362B vector network analyzer 
(VNA), as can be seen in Fig. 4. The complex permittivity measurements of the samples were recorded at room 185 
temperature using a linear frequency range between 0.5 and 20 GHz. The number of measured frequency points 
was 101. The samples were placed on a stand with a scissor lift controlled manually using a leadscrew. The probe 
was fixed on the axis of a manual positioner and connected to the VNA with a cable. The cable was attached to 
the same axis with a zip tie to reduce sagging and remained untouched during the entire measurement. The 
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stand was manually lifted until the entire probe aperture made firm contact with the sample. In this way, the 190 
coaxial probe was perfectly firm, being easier to avoid air gaps and control the pressure. The VNA was calibrated 
before each measurement using the common three standard loads (open, short and load). De-ionized water was 
used as the load in the calibration process. The dimensions of the probe head imposed size and homogeneity 
restrictions to the sample. As a reference, Table II shows the probe range of usability provided by the 
manufacturer. 195 
 
FIG. 4. Setup for dielectric spectroscopy. The open-ended coaxial probe was fixed on a manual positioner and connected to 
a vector network analyzer (VNA). 
TABLE II. Main features and requirements of the Keysight 85070E high temperature probe. 
Frequency range 200 MHz - 20 GHz 
Maximum relative permittivity of the sample 𝜖′ < 100 
Minimum loss tangent of the sample tan 𝛿 > 0.05 
Minimum sample diameter 20 mm 
Minimum sample thickness √𝜖′ mm 
Maximum granule size 0.3 mm 
 200 
Before starting measurements on human samples, the appropriateness of the coaxial probe method for colon 
tissue measurement was verified. We performed several experiments with different materials with known 
complex permittivity to determine the accuracy, minimum size of the sample (lateral dimensions and thickness) 
and repeatability.  
Accuracy: we measured the complex permittivity of several materials such as 0.051 M aqueous NaCl solution41 205 
and methanol42 (liquids with high and low relative permittivity and conductivity values, respectively). 
Subsequently, the measured complex permittivity was compared with the theoretical values.  
Minimum sample size: the minimum thickness of the sample required to obtain reliable measurements was 
evaluated using a mixture of deionized water and methanol in a certain proportion to obtain a similar complex 
permittivity as the average of colon tissues. We poured the mixture in a beaker placed on a metal surface and 210 
we measured the complex permittivity for different levels of mixture to assess the minimum thickness of the 
sample. The minimum lateral size of the sample was assessed directly with the measured complex permittivity 
data of the excised tissues (between 5-30 mm in diameter). The minimum lateral size is largely dictated by the 
probe’s geometry. Since the interrogating field is mostly confined between the outer and the inner conductor 
of the probe, the sample must cover completely this area to provide accurate measurements. The effects of 215 
different sample sizes at 10 GHz were statistically analyzed using the tissues classified as adenoma with LGD 
because it was the most populated group.  
Repeatability: we took 3 measurements of each sample in different spots to track the effects, if any, of the 
sample orientation, homogeneity and exerted pressure.  
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2.C. Clinical protocol and human sample experiments  220 
In human sample experiments, we registered details on sample preparation, measurement times and the 
temperature, to analyze if they had any impact on the measured complex permittivity. The clinical protocol, 
shown in Fig. 5, was defined in close collaboration with the medical staff to optimize the integration of the 
electromagnetic measurements into the daily clinical practice and reduce the time between excision and 
measurement. The time between excision and measurement was between 2 minutes and 2 hours depending on 225 
the type of tissue and how the samples were obtained, as follows.  
 Polyps: Nearly all polyps and superficial cancers could be resected endoscopically by routine polypectomy 
methods, including cautery or cold-snare removal43. Cold snare technique involves capturing the lesion with 
a snare wire and then close it to cut the lesion. Cautery can also be used to destroy residual polyp tissue. In 
these procedures, a liquid solution was commonly injected under the polyp to vertically separate the lesion 230 
from the deeper colon layers and reduce the chances of perforation. Endoscopists traditionally use saline, 
often with a blue dye, succinylated gelatin or adrenaline. In our measurements, the distribution of different 
solutions in the studied samples was: adrenaline in 32% of samples, succinylated gelatin in 34% of samples, 
indigo carmine dye in 44% of samples (some samples contained more than one additive). Measurements 
took place at the Endoscopy Unit of HCB, in an adjoining room to the colonoscopy boxes where the 235 
screening colonoscopies and polypectomies were performed. Immediately after the excision from the 
patient, the sample was transported to the room where we measured the complex permittivity. Just after 
the measurement, the samples were introduced in a formalin solution and were sent to the Pathology 
Department for histological analysis. Characteristics of the polyps (size, Paris classification, location into the 
colon, resection technique and additives injected) were described in a written report. Measurements were 240 
quickly obtained for these samples after the excision, around 2 minutes later. For this reason, we did not 
take any action to prevent tissue dehydration. 
 Non-polyp tissues: in clinical routine, when it is not possible to fully remove a polyp, the patient is referred 
to colectomy (surgical procedure to remove all or parts of the colon). For our study, healthy mucosa and 
invasive cancer tissues were obtained from colectomies performed in an operation room. Cancer tissue 245 
properties were measured from the available large pieces (e.g. entire colon of 1.5 m long, 10 cm width and 
1 cm of thickness; or half a colon). Healthy mucosa properties were also measured from the same colon 
pieces. The samples were not available till the end of the operation, with a delay between 30 minutes and 
2 hours. The specimen was kept as long as possible inside the patient to prevent tissue dehydration. Just 
after the surgery, the resected colon was transported to the Pathology Department where we measured 250 
the complex permittivity of tissues before being handled by the pathologist. We relied on the pathologist 
indications to select the most meaningful area for our measurements. For all the examined tissues we 
received a histology report of the lesion that was added to the colonoscopy report. 
Another important issue was the sample homogeneity. Since the measured complex permittivity represents the 
average value of all tissues present in the sensing area44, an homogeneous sample is desirable. Usually, when 255 
surgery is conducted to remove abnormal tissues, a margin of safety (e.g. healthy tissue) is also excised in order 
to ensure all abnormal tissue is fully removed. Polyps with high grade dysplasia were removed with a safety 
margin of 1 mm. Since dysplastic lesions are generally large, it was easy to select a measurement area avoiding 
the margins of healthy tissue with the help of the clinicians. Contrarily, non-neoplastic polyps were removed 
without leaving a margin of healthy tissue, as recommended in colonoscopy guidelines. 260 
 
FIG. 5. Clinical protocol for the acquisition of electromagnetic measurements within daily medical routine. 
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2.D. Complex permittivity data fitting 
The complex permittivity, 𝜖∗(𝜔) = 𝜖′(𝜔) − 𝑗𝜖′′(𝜔), is composed by a real part, 𝜖′, referred to as relative 
permittivity, and an imaginary part, 𝜖′′, often expressed in terms of conductivity, 𝜎 = 𝜖0𝜖′′𝜔 (S/m), or loss 265 
tangent, 𝑡𝑎𝑛 𝛿 = 𝜖′′ 𝜖′⁄ , which accounts for the losses (𝜖0 = 8.85 · 10
−12F/m is the free space permittivity and 
𝜔 = 2𝜋𝑓, where 𝑓 is the frequency in Hz).  
Single and multi-pole Debye46, 47 and Cole-Cole models20, 31, 32, 48, 49 have been proposed in the literature to 
parameterize the measured values of the complex wideband permittivity of biological tissues at microwave 
frequencies. Debye models have recently gained interest because they require less computational overhead47 270 
than Cole-Cole methods in the largely utilized Finite-Difference Time-Domain (FDTD) numerical methods49. For 
an optimal representation of the data, the number of poles in both models should correspond to the number of 
dielectric relaxations of the tissue over the investigated frequency range31, 32. Within our frequency range (from 
0.5 to 20 GHz), two relaxations can be identified as follows: gamma dispersion occurs with a center frequency 
near 25 GHz at body temperature due to the dipolar relaxation of water; and a small dispersion, often called 275 
delta or UHF (Ultra High Frequency) dispersion, occurs between 0.1 and 3 GHz26, 50, 51 in biological tissues. In 
some studies32, a higher order model is used because it provides more flexibility to achieve a better fit to the 
data. However, if the number of poles is too large, model parameters may be fitted to noise variations and not 
to the data itself. Another aspect that influences the parametric model fitting quality is the frequency spacing of 
the measured data. Accordingly, having a sufficient number of data points around the relaxation contributes to 280 
a more accurate modeling of the measured data, especially at low frequencies52. Our measurements content 
fewer samples in the lower frequency range than in the higher range. Therefore, we decided to accommodate 
our data above 2.5 GHz to a single-pole Debye model. For sake of comparison, we also calculated the parametric 
values for a two-pole Debye model and a single-pole Cole-Cole model32, using the following equations:  
𝜖∗(𝜔) = 𝜖∞ + ∑
∆𝜖𝑖
1 + 𝑗𝜔𝜏𝑖
𝑁
𝑖=1
+
𝜎𝑠
𝑗𝜔𝜖0
 (1) 
𝜖∗(𝜔) = 𝜖∞ +
∆𝜖
1 + (𝑗𝜔𝜏)1−𝛼
+
𝜎𝑠
𝑗𝜔𝜖0
 (2) 
Equation 1 is the multi-pole Debye model, where 𝑁 is the number of poles. The magnitude of the dispersion,  285 
∆𝜖 = 𝜖𝑠 − 𝜖∞, is given by the difference between the static permittivity (𝜖𝑠, limiting value of the relative 
permittivity obtained at alternating field frequencies where 𝜔𝜏 ≪ 1) and the permittivity at infinite frequency 
(𝜖∞, 𝜔𝜏 ≫ 1); 𝜏 is the time constant; and 𝜎𝑠 the static ionic conductivity. The Cole-Cole model (Equation 2) 
incorporates a distribution parameter (𝛼) to model the broadening of the dispersion32. 
We used the genetic algorithm (GA) available in the Matlab optimization toolbox (MATLAB and Optimization 290 
Toolbox Release 2012b, The MathWorks, Inc., Natick, Massachusetts, United States) to fit the measured relative 
permittivity and conductivity values over the band of interest to the three parametric models47. The genetic 
algorithm minimizes an objective/error function, which in our case it computes the differences between the 
experimental data and the Debye model47, giving an estimate of the quality of the fitting: 
Error =
∑ [
𝜖′(𝜔𝑘) − 𝜖𝑑′(𝜔𝑘)
median[𝜖𝑑′(𝜔)]
]
2
+ ∑ [
𝜎(𝜔𝑘) − 𝜎𝑑(𝜔𝑘)
median[𝜎𝑑(𝜔)]
]
2
𝑁
𝑘=1
𝑁
𝑘=1
𝑁
 
(3) 
where 𝜖𝑑 and 𝜎𝑑  are the relative permittivity and conductivity calculated with the Debye formulation (Equation 295 
1) at each individual measured angular frequency 𝜔𝑘. 𝜖
′, 𝜎 are the measured relative permittivity and 
conductivity respectively, and 𝜔 the vector of all frequencies of interest used in the fitting procedure. The 
genetic algorithm repeatedly modifies a population of individual solutions. An individual 𝑥 is a set of 4 Debye 
parameters [𝜖∞, ∆𝜖, 𝜏, 𝜎𝑠] to which the objective function is applied. The optimization starts from a population 
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of 50 randomly generated individuals represented by a 50× 4 matrix. At each step, the genetic algorithm 300 
randomly selects individuals from the current population and uses them as parents to produce the children for 
the next generation (crossover fraction of 0.8, Gaussian mutation with zero mean and standard deviation equal 
to 1). Over successive generations (set to a maximum of 1000), the population evolves toward an optimal 
solution minimizing the objective function. In our case the optimization is subjected to a linear constraint of the 
form 𝐴𝑥 ≤ 𝑏 to ensure that 𝜔𝜏 ≪ 1, as suggested by Mustafa et al.47. Bound value ranges were applied to each 305 
of the parameters in order to ensure that the GA did not converge towards local optima52. Commonly the 
algorithm terminates when either a maximum number of generations is produced or when the average relative 
change in the best fitness function value over generations is less than or equal to the tolerance (1·10-10). 
The chi-square goodness of fit test is used to decide whether there is any difference between the fitted data and 
the expected (measured) data. The test is defined as52: 310 
𝜒2 = ∑
(𝑂𝑖 − 𝐸𝑖)
2
𝐸𝑖
𝑛
𝑖=1
 (4) 
where 𝑂𝑖  is the fitted data, 𝐸𝑖  is the expected or measured data, and 𝑛 is the total number of frequency data 
points. Small values of the chi-Square goodness of fit test indicate that there are not significant differences 
between the fitted and expected value. 
2.E. Statistical analysis 
We performed a statistical analysis to study the effects of sample size, injected solutions, resection method, and 315 
polyp shape on the measured complex permittivity. For the analysis, we used the relative permittivity and 
conductivity values at 5 GHz of all the samples categorized as adenoma with LGD because it was the largest 
group. We also analyzed if the complex permittivity data could be used to univocally classify the different colon 
tissues. To this aim, a one-way nested analysis of variance (ANOVA) F-test was performed using the SPSS 
statistics software (IBM Corp. Released 2010. Version 19.0. Armonk, New York, United States). 320 
The performance of a decision criterion is often characterized in terms of sensitivity and specificity. The 
sensitivity, also called the true positive (TP) rate, measures the percentage of cases having a polyp or cancer that 
are correctly diagnosed as having the lesion. A false negative (FN) occurs when a negative result is reported to 
a patient that does have a lesion. The specificity, also called the true negative (TN) rate, measures the percentage 
of healthy cases that are correctly identified as not having any polyp or cancer. A false positive (FP) is reported 325 
when the test wrongly indicates that a lesion is present. The values of sensitivity and specificity are related to 
TP, FP, TN and FN values through the following formulas45: 
Sensitivity =
𝑇𝑃
𝑇𝑃+𝐹𝑁
                 Specificity =
𝑇𝑁
𝑇𝑁+𝐹𝑃
 (5) 
 
3. Results 
3.A. Calibration experiments 330 
Accuracy: results obtained from the calibration experiments showed that the open-ended coaxial method was 
adequate for our measurements. Fig. 6 represents the accuracy of the acquired measurements for 0.051 M 
aqueous NaCl solution at 25ºC, pure methanol and a mixture having similar complex permittivity to colon tissues 
(𝜖′ around 45 at 5 GHz). Both relative permittivity and conductivity values of these liquids show an excellent 
agreement with the corresponding theoretical values41,42 with an error lower than 5% in all cases.  335 
Minimum sample size: we used a mixture of liquids (𝜖′ = 45 at 5 GHz) to experimentally confirm the minimum 
measurable thickness of the sample. According to the manufacturer, the thickness of the sample must be greater 
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than √45 = 6.7 mm. Fig. 6 shows the complex permittivity measured for different amounts of mixture in a 
beaker (4, 6, 15 and 20 mm). The complex permittivity does not vary for quantities of mixture greater than 15 
mm. Below this level, the complex permittivity begins to change slightly. An error lower than a 5% for both the 340 
relative permittivity and the conductivity is obtained for mixture levels greater than 6 mm. The effect of the 
sample size was analyzed with an ANOVA F-test. We compared the p-values of adenomas with LGD of all sizes 
with adenomas with LGD larger than 10 mm. We found statistical differences (p ≤ 0.05) due to the size when we 
considered all the samples (p = 0.003 for the relative permittivity and p = 0.0001 for the conductivity), while 
there were not significant differences when considering samples larger or equal to 10 mm (p = 0.425 for the 345 
relative permittivity and p = 0.441 for the conductivity). Therefore, only samples larger than 10 mm in diameter 
accomplished the size requirements. After this selection we obtained 51 valid measurements (32 polyps, 10 
adenocarcinomas, 9 normal colon mucosa).  
 
FIG. 6. Accuracy of dielectric property measurements (relative permittivity, left; conductivity, right) for 10 mm 350 
of saline solution at 25ºC poured in a beaker, 10 mm of methanol and a mixture poured in different levels (4, 6, 
15 and 20 mm). A comparison between measured and theoretical values for the saline solution and methanol is 
provided.  
Repeatability: the orientation of the sample did not produce differences in the measured complex permittivity 
within the same tissue. Pressure over the tissue during the experiments was controlled to avoid any effect on 355 
the obtained measurements. 
3.B. Human sample experiments 
We also analyzed the effect of the resection technique and the injected solutions within the adenoma with LDG 
group. None of the solutions produced a statistically significant effect neither in the relative permittivity nor the 
conductivity, with p-values above the significance threshold (the following couple of values per solution 360 
correspond to the relative permittivity and the conductivity): indigo carmine dye, p = 0.596 and 0.407; 
succinylated gelatin, p = 0.802 and p = 0.133; adrenaline, p = 0.650 and p = 0.336. We did not expect any 
influence of the chosen solution on the measurements since they were injected underneath the lesion before 
its removal; for this reason, traces of substances should not remain inside the sample. The resection method 
(cautery and cold snare) did not cause significant changes in complex permittivity either (p-values of p = 0.8267 365 
and p = 0.2587 for the relative permittivity and conductivity, respectively). It was expected that the resection 
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method would not influence the measurements since the snare is closed at the base of the polyp, while the 
polyp itself remains intact. Cautery is only applied to remove large polyps and mainly affects the surrounding 
colon mucosa. To ensure that cautery is not influencing our measure, we selected the measurement area as far 
as possible from the cauterization zone. 370 
Using the data provided in the histology report, we identified and labeled the valid measured samples. We 
obtained 9 samples of healthy colon mucosa, 32 samples of different histological types of polyps, and 10 
adenocarcinomas. The majority of measured samples (52%) were adenomas since their size was adequate for 
the probe. Contrarily, hyperplastic polyps were scarce (12%) because they were generally small (less than 5 mm) 
and had to be excluded due to the probe size requirements. Healthy mucosa (17%) and large adenocarcinomas 375 
(19%) were only obtained from surgical colectomies. Moreover, we could only measure healthy mucosa from 
left colon colectomies as the right colon wall was too thin (only 2-mm thick) to fulfill coaxial probe thickness 
requirements, especially at lower frequencies.  
3.C. Complex permittivity of polyps, healthy mucosa and adenocarcinomas 
Using the data provided in the pathology report, we identified and labeled the valid measurements as: 380 
adenocarcinomas, healthy mucosa, hyperplastic polyps, tubular adenomas with LGD, tubular adenoma with 
HGD, villous adenomas with HGD and tubulovillous adenomas with HGD. Fig. 7 shows the plots of resulting 
relative permittivity and conductivity. Visual observation of this figure allows identifying three groups of curves 
that present differentiated dielectric properties: benign tissues (healthy mucosa and hyperplastic polyps) and 
polyps with LGD occupy the lowest cold-colored part; adenomas with HGD the intermediate magenta part; and 385 
adenocarcinomas the upper red part. This suggests a relationship between the complex permittivity of the 
samples and the grade of dysplasia, e.g. higher values of both the relative permittivity and conductivity for 
adenocarcinomas and polyps with HGD. Based on these observations, we finally classified the samples into five 
groups: adenocarcinomas, adenomas with HGD, adenomas with LGD, hyperplastic polyps and healthy colon 
mucosa, respectively. Statistical analysis confirmed that this classification produces significant differences 390 
between groups (p=0.017 for the relative permittivity and p=0.050 for the conductivity) and non-significant 
differences within groups. Polyp shape or texture did not produce changes on relative permittivity values (p = 
0.582). Fig. 8 shows the median values (solid lines) and the standard deviation (shaded bands, 95% confidence 
interval) of the relative permittivity and conductivity of the five tissue groups. It can be observed that the relative 
permittivity and conductivity of adenocarcinomas and benign tissues are clearly differentiated between 3 and 395 
10 GHz. Likewise, adenocarcinomas and adenomas with HGD can be clearly distinguished, while adenomas with 
LGD overlap with benign tissues. Therefore, the complex permittivity represents clearly the dysplasia grade of 
the adenomas: the higher the complex permittivity the higher the probability of malignancy.  
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 FIG. 7: Measured relative permittivity and conductivity of the different types of colon tissues. HGD and LGD stand for high 400 
grade dysplasia and low grade dysplasia, respectively. 
 
FIG. 8: Measured relative permittivity and conductivity of colon tissues. The lines represent the median values and the 
colored areas around the median show the 95% confidence interval. HGD and LGD stand for high grade dysplasia and low 
grade dysplasia, respectively. 405 
To examine the detection capacity of adenocarcinomas, the percentage differences between the relative 
permittivity and conductivity of adenocarcinomas and the rest of the analyzed tissues (adenoma with HGD, 
adenoma with LGD, hyperplastic polyps and healthy mucosa) were calculated at multiple frequencies, as shown 
in Fig. 9 (a) and (b). There was an average difference of 20-30% in relative permittivity between cancer and 
benign tissues for frequencies between 2 and 8 GHz, which tended to decrease as the frequency increased. The 410 
larger differences for conductivity values were found between 5 and 8 GHz (around 30-60%). Between cancer 
and adenomas with HGD, the differences were more stable over the frequency range (15% and 25% for the 
relative permittivity and conductivity, respectively, at 7 GHz). Fig. 9 (c) and (d) show the percentage differences 
between the relative permittivity and conductivity of healthy mucosa vs. all lesions for the sake of comparison 
with conventional colonoscopy. The contrast between healthy mucosa and cancer is 30-100%, and between 415 
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healthy mucosa and adenoma with HGD is 10-57%, which confirms the capacity of the complex permittivity, 
especially the conductivity, to identify dysplastic tissues. 
 
FIG. 9: Percentage differences on complex permittivity of adenocarcinoma (top) and healthy mucosa (bottom) vs. the 
remaining types of tissues for different frequencies. HGD and LGD stand for high grade dysplasia and low grade dysplasia, 420 
respectively. 
A complementary analysis of the accuracy of dielectric properties for tissue classification can be done from 
sensitivity and specificity values. Table III shows the sensitivity and specificity to detect the different histological 
types of polyps and adenocarcinomas from the rest of the colon tissues. The sensitivity and specificity were 
calculated for both the relative permittivity and the conductivity at different frequencies. Note that the 425 
performance depends on the frequency as anticipated in Fig. 9. It can be observed that the sensitivity to detect 
adenocarcinomas is 100% for all the frequencies analyzed, while the specificity is maximum (95.12%) between 
5-8 GHz using the relative permittivity data. For the adenomas with HGD the maximum sensitivity (90.91%) is 
reached using the conductivity data at 7 and 8 GHz and the specificity using both the relative permittivity and 
conductivity data is 61.76% at 9 GHz. For the adenomas with LGD a perfect sensitivity is obtained at 5 GHz using 430 
the relative permittivity data and the specificity using the relative permittivity data is 60.61% at 5 and 7 GHz. 
Finally, for the hyperplastic polyps a perfect sensitivity is obtained at all the frequencies analyzed and the 
maximum specificity using the relative permittivity data is 73.68% at 9 GHz. For all the lesions, the highest values 
of sensitivity and specificity using the conductivity are achieved using higher frequencies (9 GHz), while the 
highest performance using the relative permittivity is obtained at 5 GHz. In general, the frequency that offers a 435 
better tradeoff between sensitivity and specificity is 5 GHz.  
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TABLE III: Sensitivity (Sn) and specificity (Sp) for the relative permittivity (𝜖′) and the conductivity (𝜎) in the diagnosis of each 440 
lesion: adenocarcinoma (ACA), adenoma with high grade dysplasia (A-HGD), adenoma with low grade dysplasia (A-LGD) and 
hyperplastic polyps (HP) vs. the rest of tissues for different frequencies. The largest values among all frequencies are marked 
in bold. 
  4 GHz  5 GHz  6 GHz 
Tissue  𝜖′ Sn 𝜖′ Sp 𝜎 Sn 𝜎 Sp  𝜖′ Sn 𝜖′ Sp 𝜎 Sn 𝜎 Sp  𝜖′ Sn 𝜖′ Sp 𝜎 Sn 𝜎 Sp 
ACA  100 92.68 100 80.49  100 95.12 100 78.05  100 92.68 100 75.61 
A-HGD  81.28 61.76 72.73 58.82  90.91 55.88 72.73 58.82  81.82 55.88 90.91 58.82 
A-LGD  90.76 60.61 75.00 39.39  100 60.61 83.33 42.42  91.67 60.61 75.00 39.39 
HP  71.43 52.63 100 10.53  100 13.16 100 10.53  100 7.89 100 10.53 
 
 
7 GHz 
 
8 GHz 
 
9 GHz 
Tissue  𝜖′ Sn 𝜖′ Sp 𝜎 Sn 𝜎 Sp  𝜖′ Sn 𝜖′ Sp 𝜎 Sn 𝜎 Sp  𝜖′ Sn 𝜖′ Sp 𝜎 Sn 𝜎 Sp 
ACA  100 95.12 100 85.37  100 95.12 100 85.37  100 92.68 100 90.24 
A-HGD  72.73 61.76 90.91 58.82  81.82 58.82 90.91 58.82  81.81 53.87 90.91 61.76 
A-LGD  66.67 60.61 66.67 42.42  91.67 39.39 75.00 45.45  91.67 39.39 66.67 51.52 
HP  42.86 26.32 100 10.53  57.14 21.05 100 15.03  57.14 73.68 100 15.03 
 
3.D. Data fitting and reduction 445 
We calculated the parameters of Cole-Cole, single- and two-pole Debye models of the five colon tissue groups 
from the median measured complex permittivity over 2.5 – 20 GHz. To quantify the quality of the parametric 
models, the fitting error (Equation 3) and the chi-squared values52 were estimated, as presented in Table IV. It 
can be observed from the results that the single-pole Debye model provides the smallest fitting errors. The chi-
squared values are in the range 1 - 5 and 1 - 14 for the relative permittivity and conductivity, respectively. For 450 
single-pole Cole-Cole model, the chi-squared values are slightly higher, indicating poorer data fitting to the 
model. The Cole-Cole fitting of our measurements provided very small values of 𝛼, ranging from 1.5·10-7 to 0.05. 
Table V presents the single-pole Debye parameters of the five benign and malignant colon tissue groups derived 
from the median measured complex permittivity. Fig. 10 depicts the resultant fits for the complex permittivity 
over 2.5 - 20 GHz frequency band. The healthy colon mucosa has been compared to the data provided by Gabriel 455 
et al.33,53 showing better agreement for the conductivity rather than the relative permittivity. 
TABLE IV: Comparison of the fitting error and chi-squared values (𝜒2) for the relative permittivity (𝜖′) and conductivity (𝜎) 
of the single-pole Debye model, single-pole Cole-Cole model and two-pole Debye model, respectively. 
 Single-pole Debye Two-pole Debye Single-pole Cole-Cole 
Tissue 
Error 
(·10-5) 
𝜒2(𝜖′) 𝜒2(𝜎) 
Error 
(·10-5) 
𝜒2(𝜖′) 𝜒2(𝜎) 
Error 
(·10-5) 
𝜒2(𝜖′) 𝜒2(𝜎) 
Adenocarcinoma 2.35 5.15 1.49 0.36 5.81 7.06 0.36 5.81 7.06 
Adenoma HGD 3.64 3.03 6.59 1.17 5.45 26.55 1.17 5.45 26.55 
Adenoma LGD 1.23 2.79 13.97 1.73 4.09 38.03 1.73 4.09 38.03 
Hyperplastic 38.91 1.57 4.32 37.86 1.73 5.25 37.86 1.73 5.25 
Healthy mucosa 33.52 4.95 10.09 30.44 6.64 13.93 30.44 6.64 13.93 
 
TABLE V: Single-pole Debye model parameters of benign and malignant colon tissues (2.5 – 20 GHz). 𝜖∞ is the infinite 460 
frequency permittivity, 𝜖𝑠 is the static permittivity, 𝜏 the relaxation time constant and 𝜎𝑠 the static ionic conductivity. 
Tissue 𝜖∞ 𝜖𝑠 𝜏 (ps) 𝜎𝑠 (S/m) 
Adenocarcinoma 6.03 60.80 8.93 0.71 
Adenoma HGD 6.49 50.14 7.36 1.04 
Adenoma LGD 2.47 42.43 5.19 1.14 
Hyperplastic 5.90 46.33 6.81 1.05 
Healthy mucosa 5.05 44.79 5.62 1.23 
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FIG. 10: Single-pole Debye fits to the five categories of colorectal tissues. The healthy mucosa is compared to the available 
data in the literature (Gabriel et al. 33). HGD and LGD stand for high grade dysplasia and low grade dysplasia, respectively. 
 465 
4. Discussion 
We performed complex permittivity measurements on freshly excised colon samples of different types of polyps, 
cancer and healthy mucosa tissues obtained from 23 patients from 0.5 to 20 GHz. After a sample selection 
process, we obtained 51 valid measurements. We discarded diminutive polyps and big ones resected in 
piecemeal fashion because they were too small to be measured reliably with our probe. A thinner probe would 470 
be more adequate for these samples. Although our measurements were performed ex vivo, we put a lot of effort 
in reducing the time between excision and measurement to get closer to the in vivo conditions. All 
measurements were acquired around 2 minutes after excision, except from cancer and healthy mucosa samples 
that were delayed up to 2 hours (typically 30 minutes). With the scarcity of data available in the literature44, 54-
57, it is difficult to quantify how post-excision conditions can affect our measurements. There is a consensus in 475 
the literature56 that differences between in vivo and ex vivo properties are more important at low frequencies 
(< 100 MHz), also being quite dependent on the type of tissue. Haemmerich et al.54 measured swine liver 
resistivity (inverse of the conductivity) in-vivo and after excision for 12 h and concluded that during the first 2 h 
post-mortem (when temperature changes exist), resistivity increases by 32% at 1 MHz. In contrast, at high RF 
and microwave frequencies, the dielectric properties depend mainly on the water content and state (including 480 
temperature changes). Therefore, at higher frequencies, changes between in vivo and ex vivo properties of 
biological tissues can be minimized as long as the measurements are performed within a few hours after excision 
so that minimal liquid loss takes place57. Nonetheless, a fair amount of controversy exists on the quantification 
of this effect. O'Rourke et al.55 reported that the in vivo conductivity for normal tissue was 16% higher at 2.45 
GHz than the ex vivo conductivity, and that these changes were almost immediate. However, statistically 485 
significant differences were not found between the dielectric properties of in vivo and ex vivo malignant tissue. 
Another study44 reported no statistically significant changes into the complex permittivity of breast cancer 
tissues for times between excision and measurement smaller than 3 h and 29 min. We also controlled the sample 
temperature, which due to the small size of the samples, rapidly arrived at room temperature (between 20-
22ºC) and remained stable. Since no effect is expected due to a variation in temperature44, this effect has not 490 
been studied further in this work. 
16 
 
The obtained measurements demonstrated that complex permittivity is well correlated with the dysplasia grade 
of polyps; higher values of the relative permittivity and conductivity in the examined tissue are linked to larger 
likelihood to be cancerous tissue. From a biophysical point of view, the predominant effect in the complex 
permittivity of human tissues between 0.5 and 20 GHz is due to the orientation mechanism of water molecules 495 
(polarization). Therefore, the observed differences in complex permittivity reflect the difference in water 
content between cancer and normal colon tissues. In general, literature reports higher values of relative 
permittivity and conductivity for cancerous tissues than for normal tissues, due to the higher water content in 
the former ones30. Thus, higher complex permittivity indicates higher tissue density, higher water content and 
increasing cancer probability26, 57. In our case, two main mechanisms may be involved in elevating the water 500 
content of cancer and adenomas with HGD. First, increased mucus production in the tumor region may augment 
the extra-cellular water content. Tumor cells secrete mucus that invades the interstitial space producing large 
pools of liquid58. Secondly, dysplasia is accompanied by angiogenesis and, therefore, greater vascular water 
content. This is consistent with the recent finding according to which the angiogenic switch occurs at the onset 
of the adenoma-carcinoma sequence in CRC59, 60. As reported by Kristensen et al. 61, the greatest increase in 505 
angiogenesis occurs at the earliest stage of dysplastic transformation. Another characteristic of the complex 
permittivity of adenocarcinomas is that the relative permittivity has a steeper slope, and the peak in the 
conductivity (possibly produced by the relaxation30) is shifted with respect to the other tissues. Recent studies 
relate complex permittivity with the grade of binding of water molecules present in tissues26. The random 
molecular motion of water molecules can be quantitatively measured in vivo with diffusion-weighted magnetic 510 
resonance 61-64 through the apparent diffusion coefficient (ADC). A low ADC value means more proportion of 
bound water and increased tissue density. Higher tissue density is related to more aggressiveness or metastatic 
capacity of tumors. Conversely, healthy tissues or benign pathological processes present high ADC values, 
indicating large extracellular space, less tissue density and more water mobility. Studies in water solutions reflect 
that the complex permittivity of bound water resemble more to that of solid water that implies a shift of the 515 
relaxation to lower frequencies65 (the decay of the relative permittivity and the peak of the conductivity occurs 
at lower frequencies). Our results seem to be quite consistent with the previous reasoning: since malignant 
tissue has more bound water proportion than healthy colon tissue66, 67 the relaxation of adenocarcinomas is 
shifted to lower frequencies with respect to benign tissue one.  
Concerning the fitting results, we can observe a correlation between the static permittivity (𝜖𝑠) and tissue water 520 
content32, and, consequently, between 𝜖𝑠 and malignancy. The Cole-Cole model did not improve the results of 
the Debye model due to the negligible 𝛼 values obtained. This may be due to the high water content of colon 
tissues, and would be consistent with Gabriel's results32, in which body fluids reported negligible 𝛼 values.  Fig. 
10 shows that there is not very good agreement between our fitting of healthy mucosa and Gabriel’s one. Our 
results indicate quite lower values of complex permittivity, which can be partly explained by the different 525 
temperatures and the different species between the two sets of measurements. Gabriel’s data is from ovine 
colon samples acquired at 30º, while our data is from human colon samples at 20-22º. Joines et al.30 reported 
the complex permittivity in conditions more similar to ours (human colon samples at 23-25º) but in a lower 
frequency range (50 - 900 MHz). The values obtained by Joines et al. are also lower than Gabriel’s data. Since 
most literature finds minimal differences between species, the different measurement temperatures could 530 
largely explain the discrepancies observed in Fig. 10. Another cause of fitting inaccuracy may be caused by the 
linear frequency spacing of the complex permittivity measurements. Some studies31, 32, 52 show that linear 
spacing provided insufficient data points at lower frequencies in the Cole-Cole plots compared to measurements 
in the logarithmic scale, leading to less accurate fitting at frequencies < 1 GHz. 
We reported the sensitivity and specificity to detect adenocarcinomas and different types of polyps with our 535 
method based on their complex permittivity values. The sensitivity at 5 GHz is 100% for all lesions except for the 
adenoma with HGD that is 91%. The specificity is 95% for the adenocarcinomas, 62% for the adenomas with 
HGD, 61% for the adenomas with LGD, and 74% for the hyperplastic polyps. By changing the threshold, it is 
possible to obtain a-100% value of sensitivity for the adenomas with HGD at the expense of reducing the 
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specificity to 41%. As a reference, conventional colonoscopy reports a sensitivity and specificity of 74%–94% and 540 
88%–94%, respectively, to detect adenomas larger than 6 mm68. These values cannot be directly compared to 
the ones we obtain on ex vivo tissues since colonoscopy data is acquired in vivo69. For having a fair benchmark, 
we should first have a complete microwave-based system operated by a physician in vivo such as a conventional 
colonoscopy. Colon angulations and folds, poor cleaning, and movements of the colon, among others, are some 
of the main challenges of colon imaging when performed in vivo.  545 
We did not find statistical significant differences in dielectric properties due to the shape of the polyps. This may 
suggest that the complex permittivity could help to detect subtle (slightly elevated, sessile or flat) polyps, which 
are the most difficult lesions to detect endoscopically. A study that tracked the performance of endoscopists in 
the detection of flat polyps reported low detection rates (1.5-3.5%) during first 200 colonoscopies and 7.4% after 
1000 colonoscopies69. Flat lesions are also more likely to harbor advanced histology (HGD or early cancer) 550 
compared to pedunculated or sessile lesions irrespective of the size. Therefore, detection and subsequent 
removal of these lesions is of paramount importance for improving the efficacy of colonoscopy in preventing 
the development of CRC.  
Apart from the detection itself, the proposed method adds in situ diagnosis capacity. With conventional 
colonoscopy, when a polyp is found, clinicians have to make decisions about resecting or not depending on the 555 
type of polyp and its risk to degenerate. This information is not available during colonoscopy and endoscopists 
only rely on subjective observations based on different surface or vascular patterns. The accurate diagnosis is 
only confirmed after excision with the pathology analysis. For this reason, the current protocol establishes to 
resect and analyze all lesions found during the exploration, which is time consuming and costly. The 
measurements presented in this paper, show the possibility to distinguish malignant tissues from healthy 560 
mucosa and benign colon tissues, since there is not overlapping between their complex permittivity below 10 
GHz. Moreover, the grade of dysplasia can be inferred from the complex permittivity as it increases with 
dysplasia. Accordingly, polyps with LGD present a complex permittivity very close to that of the benign tissues 
and polyps with HGD occupy the intermediate region between healthy tissues and cancer.  
5. Conclusion 565 
In summary, we measured the complex permittivity of freshly excised healthy colon, different types of polyps 
and colon cancerous tissues of human ex vivo samples between 0.5 and 20 GHz from 23 patients. The obtained 
measurements, validated through pathological analysis, showed that the complex permittivity correlates with 
the grade of dysplasia of colon epithelium and thus can be used to quantify the grade of dysplasia or malignancy 
of the colon lesions. Our initial results reported a sensitivity of 100-91% and a specificity of 61-95% to detect 570 
adenocarcinomas, adenomas, and hyperplastic polyps from healthy mucosa. This study is the first 
demonstration of the feasibility of using complex permittivity data to provide complementary functional 
information to conventional colonoscopy. The development of a fully integrated multimodal (optical and 
microwave) colon imaging platform has the potential of making a positive impact of the management of CRC 
patients. 575 
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